Steroid use during COVID-19 infection and hyperglycemia - What a physician should know.

Authors :: Sosale A
Sosale B
Kesavadev J
Chawla M
Reddy S
Saboo B
Misra A
Source :: Diabetes & metabolic syndrome [Diabetes Metab Syndr] 2021 Jul-Aug; Vol. 15 (4), pp. 102167. Date of Electronic Publication: 2021 Jun 10.
Publication Year :: 2021
Abstract: Background and Aims: The COVID-19 pandemic continues to challenge us. Despite several strides in management, steroids remain the mainstay for treating moderate to severe disease and with it arises challenges such as hyperglycemia. The review aims to enhance awareness amongst physicians on steroid use and hyperglycemia.<br />Methods: An advisory document describing various strategies for hyperglycemia management was prepared in the public interest by DiabetesIndia.<br />Results: The review provides awareness on steroids and hyperglycemia, adverse outcomes of elevated blood glucose levels and, advice at the time of discharge.<br />Conclusions: The article emphasizes enhancing awareness on effective management of hyperglycemia during COVID-19.<br /> (Copyright © 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.)

Subjects :: COVID-19 transmission
COVID-19 virology
Humans
Hyperglycemia virology
COVID-19 complications
Hyperglycemia drug therapy
SARS-CoV-2 isolation & purification
Steroids therapeutic use

Full Text Access

Tools